Atlas Trials

Saliva Insulin as Biomarker of Risk Factors for Metabolic Dysregulation and Caries

Clinical trial NCT05211843 · COMPLETED

Trial details

NCT number
NCT05211843
Sponsor
Jodi Stookey
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
CariesMetabolomic Profile
Start date
2022-10-12
Primary completion
2023-12-31
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.